Olive Leaf Extract Wards off Hypertension

August 27, 2008

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

WADENSWIL, Switzerland—A recent open study found the olive leaf extract EFLA®943 (from Frutarom) has antihypertensive and cholesterol-lowering action (Phytother. Res. 2008;22:1239–1242) (DOI:10.1002/ptr.2455). Forty borderline, hypertensive, monpzygotic twins were assigned in pairs to groups receiving either 500 mg/d or 1000 mg/d of EFLA®943 for eight weeks, or advice on a favorable lifestyle. Blood pressure changed significantly within pairs, depending on the dose, with mean systolic differences of ≤ 6 mm Hg (500 mg vs. control) and ≤ 13 mm Hg (1000 vs. 500 mg), and diastolic differences of ≤ 5 mm Hg. After eight weeks, mean blood pressure remained unchanged from baseline in controls and the low-dose group, but had significantly decreased for the high-dose group. Cholesterol levels decreased for all treatments with significant dose-dependent, within-pair differences for low-density lipoprotein (LDL) cholesterol. None of the other parameters showed significant changes or consistent trends.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like